Health-care companies fell, but not by as much as the broad market, as traders positioned for growth in drug and device sales this year.
Shares of medical-device maker Medtronic rose after it reported fiscal third-quarter operating earnings ahead of Wall Street estimates. Obesity drug makers Eli Lilly and Novo Nordisk slipped, but remained significantly higher for the year to date.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
02-20-24 1803ET
